Sharon Shacham - Chief Scientific Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sharon Shacham since 7/7/2023

Holdings reported by Sharon Shacham for Karyopharm Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 958,131 $786 K $0.82 Mar 29, 2022 Direct
Common Stock 713,757 $585 K $0.82 Mar 29, 2022 By Spouse
Stock Option (right to buy) 90,000 Mar 29, 2022 Direct Common Stock

Transactions reported by Sharon Shacham for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership